Item 7A. Quantitative and Qualitative Disclosures About Market Risk
ITEM 7A.
QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK
As part of our ongoing operations,
we are exposed to interest rate fluctuations on our borrowings. As more fully described in Note 12 “Fair Value Measurements of Financial
Instruments” to the Consolidated Financial Statements included in “Item 8. Financial Statements and Supplementary Data”
of this Annual Report on Form 10-K for our fiscal year ended October 2, 2021, we use interest rate swap agreements to manage these risks.
These instruments are not used for speculative purposes but are used to modify variable rate obligations into fixed rate obligations.
At October 2, 2021, we had two
variable rate debt instruments outstanding that are impacted by changes in interest rates. The interest rate of both variable rate debt
instruments is equal to the lender’s LIBOR Rate plus two and one-quarter percent (2.25%) per annum. The debt instruments further
provide that the “LIBOR Rate” is a rate of interest equal to the British Bankers Association LIBOR Rate or successor thereto
approved by the lender if the British Bankers Association is no longer making a LIBOR rate available. In January 2013, we refinanced the
mortgage loan encumbering the property where our combination package liquor store and restaurant located at 4 N. Federal Highway, Hallandale,
Florida, (Store #31) operates, which mortgage loan is held by an unaffiliated third party lender (the “$1.405M Loan”). In
December 2016, we closed on a secured revolving line of credit which entitled us to borrow, from time to time through December 28, 2017,
up to $5,500,000 (the “Credit Line”), which on December 28, 2017 converted to a term loan (the “Term Loan”).
As a means of managing our interest
rate risk on these debt instruments, we entered into interest rate swap agreements with our unrelated third party lender to convert these
variable rate debt obligations to fixed rates. We are currently party to the following two (2) interest rate swap agreements:
(i) The
first interest rate swap agreement entered into in January 2013 relates to the $1.405M Loan (the “$1.405M Term Loan Swap”).
The $1.405M Term Loan Swap requires us to pay interest for a twenty (20) year period at a fixed rate of 4.35% on an initial amortizing
notional principal amount of $1,405,000, while receiving interest for the same period at LIBOR – 1 Month, plus 2.25%, on the same
amortizing notional principal amount. We determined that at October 2, 2021, the interest rate swap agreement is an effective hedging
agreement and the fair value was not material; and
(ii)
The second interest rate swap agreement entered into in December 2016 and became effective December 28, 2017, relates to the Term Loan
(the “Term Loan Swap”). The Term Loan Swap requires us to pay interest for a five (5) year period at a fixed rate of 4.61%
on an initial amortizing notional principal amount of $5,500,000, while receiving interest for the same period at LIBOR – 1 Month,
plus 2.25%, on the same amortizing notional principal amount. We determined that at October 2, 2021, the interest rate swap agreement
is an effective hedging agreement and the fair value was not material
Pursuant to our institutional
lender, beginning January 1, 2022 it will no longer originated, renew or modify loans at LIBOR, except in limited situations which include
transactions which reduce or hedge LIBOR exposure on contracts entered into before January 1, 2022. LIBOR rates will be published until
June 30, 2023 and all principal and interest of the $1.405M Loan will be due in full on January 23, 2023 and all principal and interest
of the Term Loan will be fully amortized and paid in full as of December 28, 2022 so the discontinuance of LIBOR rates will have no impact
on us.
At October 2, 2021, our cash resources
earn interest at variable rates. Accordingly, our return on these funds is affected by fluctuations in interest rates.
There is no assurance that interest
rates will increase or decrease over our next fiscal year or that an increase will not have a material adverse effect on our operations.
ITEM 8.
FINANCIAL STATEMENTS AND SUPPLEMENTARY DATA .
Our Consolidated Financial Statements
and supplementary data are on pages F-1 through F-6.
54
Table of Contents
ITEM 9.
CHANGES IN AND DISAGREEMENTS WITH ACCOUNTANTS ON ACCOUNTING AND FINANCIAL DISCLOSURES.
None
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.